Stockscreener 앱 받기
18.01
0.83%
-0.15
시간 외 거래:
18.01
전일 마감가:
$18.16
열려 있는:
$17.97
하루 거래량:
22,421
Relative Volume:
0.35
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.33%
1개월 성능:
-8.67%
6개월 성능:
+3.39%
1년 성능:
+22.89%
1일 변동 폭
$17.97
$18.07
1주일 범위
$17.97
$18.87
52주 변동 폭
$13.13
$21.88
Kraneshares Msci All China Health Care Index Etf Stock (KURE) Company Profile
명칭
Kraneshares Msci All China Health Care Index Etf
전화
-
주소
-
KURE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KURE
Kraneshares Msci All China Health Care Index Etf
|
18.01 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.36 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
678.84 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
679.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.79 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
611.75 | 124.43B | 0 | 0 | 0 | 0.00 |
Kraneshares Msci All China Health Care Index Etf 주식(KURE)의 최신 뉴스
7 Best China ETFs for December 2025 - NerdWallet
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Precision Trading with Kraneshares Msci All China Health Care Index Etf (KURE) Risk Zones - news.stocktradersdaily.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove… - inkl
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' - Benzinga
Trading the Move, Not the Narrative: (KURE) Edition - news.stocktradersdaily.com
KURE - KraneShares
KCAI - KraneShares
KEMX - KraneShares
KGRN - KraneShares
KBA - KraneShares
(KURE) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
KraneShares MSCI All China Health Care Index ETF (NY: - FinancialContent
KraneShares SSE STAR Market 50 Index ETF (KSTR) stock price, news, quote and history - Yahoo! Finance Australia
Should EM Investors Trim or Retain Their China Exposure? - ETF Database
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Capitalize on China Healthcare Fundraising With KURE - ETF Database
Investing in Emerging Markets: CNXT, KSTR and More Top-Performing ETFs - NerdWallet
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Mark Cuban Exposes How Wholesalers Force Pharmacies… - inkl
China Update: New IPOs, Healthcare Momentum, New Hydroelectric Dam - Seeking Alpha
China Thematic Update: New IPOs (KSTR), Healthcare Momentum From Regulatory Reprieve & Innovation (KURE), New Hydroelectric Dam (KGRN) - KraneShares
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
5 Biggest Pharmaceutical ETFs in 2025 - Nasdaq
Mark Cuban Says Cutting PBM Fees Won't Reduce… - inkl
Long Term Trading Analysis for (KURE) - news.stocktradersdaily.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says… - inkl
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - inkl
(KURE) Trading Signals - news.stocktradersdaily.com
7 Best China ETFs for July 2025 - NerdWallet
china growth - Syfe
KURE: Capitalizing on China’s Healthcare Revolution - KraneShares
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Yahoo Finance
Bank of America Corp DE Lowers Stock Holdings in KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) - Defense World
Humanoid Robotics ETF | KOID | Invest in the Future of Embodied AI - KraneShares
KraneShares MSCI All China Health Care Index ETF (KURE) Short Interest Ratio and Volume 2025 - MarketBeat
Best Roth IRA Investments - NerdWallet
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion - Benzinga
Top 4 ETFs for China Exposure After Tariff Relief | Stock Index | Business Insurance News, Analysis & Articles - FinancialContent
China's Healthcare ETFs Outpace U.S. Competitors - ETF Trends
3 ETFs Thriving in April’s Market Chaos—Are You Missing Out? - MarketBeat
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
Six ETFs for investors seeking diversification outside North America - The Globe and Mail
KURE ETF Holdings List — BMV:KURE - TradingView
KWEB - KraneShares
New Drivers For China Healthcare: AI Med-Tech Innovation, Cancer Treatment, & Favorable Balance of Trade - KraneShares
China's Market Rebound: Is The NPC Meeting A Turning Point For Investors? - Benzinga
A KURE for China Tariff Concerns - ETF Trends
2025 China Outlook: A Recipe For Re-Rating - Forbes
Kraneshares Msci All China Health Care Index Etf (KURE) 재무 분석
Kraneshares Msci All China Health Care Index Etf (KURE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.97%
0.24%
자본화:
|
볼륨(24시간):